Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Jacobs

Showing results (91-100 of 264) with videos related to

Pageof 27
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1994
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxoneG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|June 1, 1991
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodologyM A Visalli, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 4, 1998
Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophiliaM A Visalli, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonadsM R Jacobs, S C Aronoff, S Johenning, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 21, 1978
Escherichia coli gastro-enteritis in adultsR M Robins-Browne, M R Jacobs, H J Koornhof
International Journal of Antimicrobial Agents|April 15, 2004
Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000L M Koeth, D Felmingham, M R Jacobs, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1992
Evaluation of the E-Test for susceptibility testing of pneumococciM R Jacobs, S Bajaksouzian, P C Appelbaum, et al.
Pageof 27

Showing results (91-100 of 264) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|December 1, 1994
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxoneG A Pankuch, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|June 1, 1991
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodologyM A Visalli, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|August 4, 1998
Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophiliaM A Visalli, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonadsM R Jacobs, S C Aronoff, S Johenning, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 21, 1978
Escherichia coli gastro-enteritis in adultsR M Robins-Browne, M R Jacobs, H J Koornhof
International Journal of Antimicrobial Agents|April 15, 2004
Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000L M Koeth, D Felmingham, M R Jacobs, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1992
Evaluation of the E-Test for susceptibility testing of pneumococciM R Jacobs, S Bajaksouzian, P C Appelbaum, et al.
Pageof 27